Status:
COMPLETED
TMS for Post Stroke Depression
Lead Sponsor:
Amelia Adcock
Conditions:
Post-stroke Depression
Eligibility:
All Genders
22-85 years
Phase:
NA
Brief Summary
The purpose of this study is to find alternative treatments for patient's suffering from depression after having a stroke.This study aims to show that accelerated rTMS is a safe, effective,and conveni...
Detailed Description
The primary objectives of this project are as follows: 1. To assess the efficacy TMS in PSD. We hypothesize that there will be a decrease in the HAMD score in patients receiving TMS 2. To assess the ...
Eligibility Criteria
Inclusion
- Between the ages of 22-85 years old
- Radiographic evidence of acute or subacute stroke
- Ischemic stroke diagnosed within the last 2 weeks to 6 months
- HAMD depression score 8 or greater
- Able to provide written informed consent
- Agree to participate in all study procedures
Exclusion
- Metallic objects or neurostimulators implanted intracranially
- Stroke in the area of stimulation
- Current thoughts of SI or self-harm as assessed by the M.I.N.I. Suicide Scale score \> 8
- ASRM (Altman Self Rating Mania Scale) score \> 6 (6 or above indicates likelihood of manic symptoms)
- Current use of illicit substances
- Known history of epilepsy or seizure disorder
- Clinically significant EKG abnormalities including QTC prolongation \>450 ms in men or \>480 ms in women
Key Trial Info
Start Date :
October 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04093843
Start Date
October 24 2018
End Date
June 30 2020
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West Virginia University
Morgantown, West Virginia, United States, 26506